Literature DB >> 12390159

The capillary blood flow in ischaemic type central retinal vein occlusion: the effect of laser photocoagulation.

Sema Arvas1, Ozcan Ocakoglu, Sehirbay Ozkan.   

Abstract

PURPOSE: To determine the effect of photocoagulation on retinal blood flow (RBF) in eyes with ischaemic type central retinal vein occlusion (CRVO). PATIENTS AND METHODS: Retinal blood flow was measured in 12 eyes with CRVO, 12 fellow eyes and 12 eyes of 12 age-matched healthy subjects using the Heidelberg retinal flowmeter (HRF). Microvascular blood flow values (volume, flow, velocity) were recorded from the upper temporal retina and macula. Eyes were re-examined 1 month after photocoagulation. We investigated whether there was a difference in RBF measurements before and after photocoagulation treatment.
RESULTS: In eyes with CRVO, mean RBF values (volume, flow and velocity) obtained from the upper temporal retina increased significantly after treatment (paired t-test, p < 0.05). In contrast, mean RBF values from the macula were unaffected by photocoagulation (paired t-test, p > 0.05). Retinal blood flow values from the upper temporal retina obtained from control subjects were significantly higher than the values in eyes with CRVO before and after photocoagulation (unpaired t-test, p < 0.05), but there was no significant difference between control subjects and CRVO patients in RBF values from the macula (unpaired t-test, p > 0.05). Mean RBF values were significantly higher in CRVO patients' fellow-eyes before photocoagulation in the eyes with CRVO (paired t-test, p < 0.05) but were lower than in age-matched healthy control eyes (unpaired t-test, p < 0.05). Macular blood flow did not differ between the eyes with CRVO and fellow eyes (paired t-test, p > 0.05).
CONCLUSION: Laser photocoagulation increased retinal blood flow in eyes with CRVO, but RBF did not reach normal values. Photocoagulation was found to have no effect on RBF in the macular area.

Entities:  

Mesh:

Year:  2002        PMID: 12390159     DOI: 10.1034/j.1600-0420.2002.800506.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  5 in total

Review 1.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

2.  RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION.

Authors:  Makiko Matsumoto; Kiyoshi Suzuma; Yoshihisa Yamada; Eiko Tsuiki; Azusa Fujikawa; Takashi Kitaoka
Journal:  Retina       Date:  2018-02       Impact factor: 4.256

3.  Retinal Vascular Resistance Significantly Correlates With Visual Acuity After 1 Year of Anti-VEGF Therapy in Central Retinal Vein Occlusion.

Authors:  Makiko Matsumoto; Kiyoshi Suzuma; Fumito Akiyama; Kanako Yamada; Shiori Harada; Eiko Tsuiki; Takashi Kitaoka
Journal:  Transl Vis Sci Technol       Date:  2021-09-01       Impact factor: 3.283

4.  The clinical relevance of ultra-widefield angiography findings in patients with central retinal vein occlusion and macular oedema receiving anti-VEGF therapy.

Authors:  Luke Nicholson; Clara Vazquez-Alfageme; Piyali Sen; Namritha V Patrao; Tunde Peto; Yit Yang; Sobha Sivaprasad; Philip G Hykin
Journal:  Eye (Lond)       Date:  2021-05-25       Impact factor: 4.456

Review 5.  Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel.

Authors:  Heinrich Gerding; Jordi Monés; Ramin Tadayoni; Francesco Boscia; Ian Pearce; Siegfried Priglinger
Journal:  Br J Ophthalmol       Date:  2014-07-29       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.